HHS.gov @HHSGov
Today @NIH announced the launch of a Phase 3 clinical trial to test candidate vaccine mRNA-1273, developed by NIH, @NIAIDNews, and @moderna_tx, to prevent #COVID19. #ACTIV supported the protocol development and Operation #WarpSpeed provided funding. https://t.co/WXDJkiHT05 https://t.co/1PPxP4BOST — PolitiTweet.org